Singapore - engelska - HSA (Health Sciences Authority)

pfizer private limited - talazoparib tosylate eqv talazoparib - capsule - talazoparib tosylate eqv talazoparib 1 mg

Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

pfizer laboratories (pty) ltd - capsules - see ingredients - each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin

USA - engelska - NLM (National Library of Medicine)

a-s medication solutions - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: - management of neuropathic pain associated with diabetic peripheral neuropathy - management of postherpetic neuralgia - adjunctive therapy for the treatment of partial-onset seizures in patients 4 years of age and older - management of fibromyalgia - management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin capsules during pregnancy. to provide informa

USA - engelska - NLM (National Library of Medicine)

pfizer manufacturing belgium nv - tozinameran (unii: 5085zfp6sj) (tozinameran - unii:5085zfp6sj), famtozinameran (unii: jsv288q5cv) (famtozinameran - unii:jsv288q5cv) - pfizer-biontech covid-19 vaccine, bivalent (original and omicron ba.4/ba.5) is authorized for use under an emergency use authorization (eua) for active immunization to prevent coronavirus disease 2019 (covid-19) caused by severe acute respiratory syndrome coronavirus 2 (sars-cov-2) in individuals 5 years of age and older. this eua prescribing information pertains only to pfizer-biontech covid-19 vaccine, bivalent (original and omicron ba.4/ba.5), hereafter referred to as pfizer-biontech covid-19 vaccine, bivalent, supplied in a multiple dose vial with an orange cap and a label with an orange border, which is authorized for use in individuals 5 through 11 years of age. the vial labels state: age 5y to <12y. the carton labels state: for age 5 years to <12 years. do not administer pfizer-biontech covid-19 vaccine, bivalent to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the pfizer-biontech covid-19 vaccine or the pfizer-biontech covid-19 vaccine, bivalent [

Singapore - engelska - HSA (Health Sciences Authority)

pfizer private limited - sunitinib malate - capsule - 12.5mg - sunitinib malate 12.5mg

Singapore - engelska - HSA (Health Sciences Authority)

pfizer private limited - sunitinib malate - capsule - 25 mg - sunitinib malate 25 mg

Singapore - engelska - HSA (Health Sciences Authority)

pfizer private limited - sunitinib malate - capsule - 50 mg - sunitinib malate 50 mg

Singapore - engelska - HSA (Health Sciences Authority)

pfizer pfe private limited - pregabalin - capsule - 200.00mg - pregabalin 200.00mg

Singapore - engelska - HSA (Health Sciences Authority)

pfizer pfe private limited - pregabalin - capsule - 300.00mg - pregabalin 300.00mg

Singapore - engelska - HSA (Health Sciences Authority)

pfizer private limited - estramustine phosphate sodium eqv estramustine - capsule - 140 mg - estramustine phosphate sodium eqv estramustine 140 mg